Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis.

de la Guardia RD, Lopez-Millan B, Roca-Ho H, Bueno C, Gutiérrez-Agüera F, Fuster JL, Anguita E, Zanetti SR, Vives S, Nomdedeu J, Sackstein R, Lavoie J, Gónzalez-Rey E, Delgado M, Rosu-Myles M, Menendez P.

Haematologica. 2019 Feb;104(2):e54-e58. doi: 10.3324/haematol.2018.196568. Epub 2018 Sep 20. No abstract available.

2.

Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.

Horiguchi H, Kobune M, Kikuchi S, Yoshida M, Murata M, Murase K, Iyama S, Takada K, Sato T, Ono K, Hashimoto A, Tatekoshi A, Kamihara Y, Kawano Y, Miyanishi K, Sawada N, Kato J.

Haematologica. 2016 Apr;101(4):437-47. doi: 10.3324/haematol.2015.134932. Epub 2016 Jan 22.

3.

Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery.

Trento C, Marigo I, Pievani A, Galleu A, Dolcetti L, Wang CY, Serafini M, Bronte V, Dazzi F.

Haematologica. 2017 May;102(5):818-825. doi: 10.3324/haematol.2016.155390. Epub 2017 Feb 9.

4.

The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.

Sorokina T, Shipounova I, Bigildeev A, Petinati N, Drize N, Turkina A, Chelysheva E, Shukhov O, Kuzmina L, Parovichnikova E, Savchenko V.

Eur J Haematol. 2016 Sep;97(3):245-52. doi: 10.1111/ejh.12713. Epub 2016 Jan 3.

PMID:
26643284
5.

Concise Review: Adaptation of the Bone Marrow Stroma in Hematopoietic Malignancies: Current Concepts and Models.

Doron B, Handu M, Kurre P.

Stem Cells. 2018 Mar;36(3):304-312. doi: 10.1002/stem.2761. Epub 2018 Jan 1. Review.

6.

Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.

Tang C, Li MH, Chen YL, Sun HY, Liu SL, Zheng WW, Zhang MY, Li H, Fu W, Zhang WJ, Liang AB, Tang ZH, Hong DL, Zhou BS, Duan CW.

J Exp Clin Cancer Res. 2018 Aug 29;37(1):204. doi: 10.1186/s13046-018-0859-3.

7.

Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation.

Shipounova IN, Petinati NA, Bigildeev AE, Drize NJ, Sorokina TV, Kuzmina LA, Parovichnikova EN, Savchenko VG.

Leuk Lymphoma. 2017 Feb;58(2):408-417. Epub 2016 May 31.

PMID:
27244369
8.

Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis.

Vianello F, Villanova F, Tisato V, Lymperi S, Ho KK, Gomes AR, Marin D, Bonnet D, Apperley J, Lam EW, Dazzi F.

Haematologica. 2010 Jul;95(7):1081-9. doi: 10.3324/haematol.2009.017178. Epub 2010 Feb 23.

9.

Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia.

Robertson MJ, Soiffer RJ, Freedman AS, Rabinowe SL, Anderson KC, Ervin TJ, Murray C, Dear K, Griffin JD, Nadler LM, et al.

Blood. 1992 May 1;79(9):2229-36.

PMID:
1571539
10.

Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.

Chandran P, Le Y, Li Y, Sabloff M, Mehic J, Rosu-Myles M, Allan DS.

Leuk Res. 2015 Apr;39(4):486-93. doi: 10.1016/j.leukres.2015.01.013. Epub 2015 Feb 2.

PMID:
25703353
11.
12.

Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro.

Liang X, Su YP, Kong PY, Zeng DF, Chen XH, Peng XG, Zou ZM, Xu H.

Int J Radiat Biol. 2010 Mar;86(3):230-7. doi: 10.3109/09553000903422555.

PMID:
20201651
13.

LTβR expression on hematopoietic cells regulates acute inflammation and influences maturation of myeloid subpopulations.

Wege AK, Huber B, Wimmer N, Männel DN, Hehlgans T.

Innate Immun. 2014 Jul;20(5):461-70. doi: 10.1177/1753425913497242. Epub 2013 Aug 12.

PMID:
23940077
14.

Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.

Varga G, Kiss J, Várkonyi J, Vas V, Farkas P, Pálóczi K, Uher F.

Pathol Oncol Res. 2007;13(4):311-9. Epub 2007 Dec 25.

16.

Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.

Kumar B, Garcia M, Weng L, Jung X, Murakami JL, Hu X, McDonald T, Lin A, Kumar AR, DiGiusto DL, Stein AS, Pullarkat VA, Hui SK, Carlesso N, Kuo YH, Bhatia R, Marcucci G, Chen CC.

Leukemia. 2018 Mar;32(3):575-587. doi: 10.1038/leu.2017.259. Epub 2017 Aug 17.

17.

Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells.

Serafini M, Sacchetti B, Pievani A, Redaelli D, Remoli C, Biondi A, Riminucci M, Bianco P.

Stem Cell Res. 2014 May;12(3):659-72. doi: 10.1016/j.scr.2014.01.006. Epub 2014 Feb 8.

18.

Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.

Mahlknecht U, Schönbein C.

Haematologica. 2008 Mar;93(3):443-6. doi: 10.3324/haematol.11796. Epub 2008 Feb 11.

19.

Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.

Azuma K, Umezu T, Imanishi S, Asano M, Yoshizawa S, Katagiri S, Ohyashiki K, Ohyashiki JH.

Leuk Res. 2017 Nov;62:23-28. doi: 10.1016/j.leukres.2017.09.008. Epub 2017 Sep 21.

PMID:
28964959
20.

Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.

Wang Z-, Yu H-, Cao F-, Liu Z-, Liu Z-, Feng W-, Liu X-, Yu Y-, Xiao Y, Li L-, Zhou J.

Ann Hematol. 2019 Feb;98(2):473-479. doi: 10.1007/s00277-018-3523-2. Epub 2018 Oct 19.

PMID:
30341538

Supplemental Content

Support Center